031390.KQ
Green Cross Cell Corporation [031390.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
031390.KQ Stock Summary
In the News
031390.KQ Financial details
Company Rating
-
Market Cap
0
Income
6.48B
Revenue
2034.74B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
274
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
169.4
EPS next Y
-
EPS next Q
-
EPS this Y
-40.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
11.96%
Revenue last 5Y
6.07%
Revenue Q/Q
22.37%
EPS Q/Q
-65.69%
-
-
-
-
SMA20
33.33%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
38150-39300
52W High
-1.91%
52W Low
+1.05%
RSI
-
Rel Volume
0.21
Avg Volume
847.87K
Volume
175.88K
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.644973
-
-
Volatility
0%, 7861.54%
Prev Close
-
Price
38550
Change
-
Company Profile
- Volume Average 847.87K
- Employee 274
- Headquarters Yongin-Si,KR
-
Website
http://www.greencrosscell.com 
Green Cross Cell Corporation develops, manufactures, and sells anti-cancer immune cell therapy for liver cancer in South Korea and internationally. It also offers cord blood storage and immune cell bank services. The company was founded in 1992 and is headquartered in Yongin, South Korea.
